Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Commissioner’s National Priority Voucher (CNPV)
Biotech
Makary FDA reforms ‘continue to move forward’ despite turmoil
Makary's namesake program, the controversial Commissioner’s National Priority Voucher, remains unchanged in name and direction, Fierce has learned.
Darren Incorvaia
May 26, 2026 10:27am
Fierce Pharma
Biopharma rallies behind Pazdur to lead FDA. But is he willing?
May 14, 2026 11:05am
‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics
May 4, 2026 3:30am
Fierce Pharma
Regeneron ushers in new era with inaugural gene therapy approval
Apr 23, 2026 3:22pm
Trump orders FDA to fast-track reviews of psychedelic drugs
Apr 20, 2026 5:30am
Fierce Pharma
FDA solicits feedback on national priority voucher pilot
Mar 23, 2026 9:35am